Authors
Yiyang Yuan, Danni Luo, Lingge Shi, Yanzhu Liu, Yunbo Zhao, Haomiao Dou, Feiyan Ma, Guangda Xu, Zhili Xiong
Published in
Analytical methods : advancing methods and applications. Jul 08, 2026. Epub Jul 08, 2026.
Abstract
Chiral discrimination of drug enantiomers is essential in neurodegenerative disease therapy. This study presented a chiral sensing platform utilizing L-histidine-functionalized copper nanoparticles (L-His@Cu NPs) with peroxidase-mimicking activity for the colorimetric detection of DOPA enantiomers. L-His@Cu NPs exhibited enhanced affinity and catalytic inhibition toward L-DOPA over its D-counterpart. Under optimized conditions, the sensor demonstrated a wide linear detection range of 0.02-4 mM and detection limits of 0.0107 mM for D-DOPA and 0.0129 mM for L-DOPA. The system also enabled enantiomeric excess analysis with high accuracy. Practical application in real pharmaceutical and water samples showed excellent recovery (92.32-104.18%) and stability over 50 days. This work offered a simple, cost-effective, and reliable strategy for on-site chiral discrimination, holding significant potential for pharmaceutical analysis and quality control.
PMID:
42418172
Bibliographic data and abstract were imported from PubMed on 08 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0